A clinical study of biomarkers of innate and adaptive immune activation associated with symptoms and immune responses after administration of a single dose of a quadrivalent inactivated split virus influenza vaccine to healthy young adults.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2017
At a glance
- Drugs GSK 2321138A (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 28 Aug 2017 New trial record